Lipella Pharmaceuticals I... (LIPO)
2.96
-0.11 (-3.58%)
At close: Jan 15, 2025, 3:58 PM
2.90
-2.01%
After-hours Jan 15, 2025, 05:15 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -1.33 | -55.4 | -17.64 | -492.64 | -529.3 |
| PS Ratio | 13.62 | 781.01 | 127.35 | 34.04 | 47.12 |
| PB Ratio | 1.95 | 30.76 | 23.20 | 70.66 | -276.62 |
| P/FCF Ratio | -1.93 | -78.54 | -33.39 | -1.15K | -836.87 |
| P/OCF Ratio | -1.94 | -78.54 | -33.39 | -1.15K | -836.87 |
| OCF/S Ratio | -7.01 | -9.94 | -3.81 | -0.03 | -0.06 |
| Debt / Equity Ratio | 0.04 | 0.09 | 0.20 | 0.84 | -0.85 |
| Quick Ratio | 8.90 | 5.02 | 5.31 | 3.37 | 0.72 |
| Current Ratio | 8.90 | 4.92 | 5.31 | 3.37 | 0.72 |
| Asset Turnover | 0.13 | 0.03 | 0.13 | 1.01 | 5.84 |
| Interest Coverage | -437.5 | -269.42 | -280.34 | -7.14 | -6.41 |
| Return on Equity (ROE) | -1.47 | -0.56 | -1.32 | -0.14 | 0.52 |
| Return on Assets (ROA) | -1.29 | -0.44 | -0.93 | -0.07 | -0.52 |
| Return on Capital (ROIC) | -1.49 | -0.54 | -1.15 | -0.08 | 1.15 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -575.87% | -1.28K% | -461.71% | -1.48% | 1.71% |
| Net Profit Margin | -1.03K% | -1.41K% | -721.89% | -6.91% | -8.9% |
| Pretax Profit Margin | -1.03K% | -1.41K% | -719.3% | -6.41% | -8.9% |
| Operating Profit Margin | -1.06K% | -1.41K% | -738.71% | -5.91% | -7.74% |
| FCF Margin | -703.84% | -994.35% | -381.45% | -2.97% | -5.63% |
| EBITDA Margin | -1.02K% | -1.41K% | n/a | -5.58% | 0.05% |